CARNOVALE, VINCENZO
 Distribuzione geografica
Continente #
AS - Asia 1.753
NA - Nord America 1.650
EU - Europa 1.195
SA - Sud America 260
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 50
OC - Oceania 5
Totale 5.010
Nazione #
US - Stati Uniti d'America 1.586
SG - Singapore 711
RU - Federazione Russa 503
VN - Vietnam 374
CN - Cina 333
IT - Italia 286
BR - Brasile 216
HK - Hong Kong 117
DE - Germania 76
FR - Francia 72
FI - Finlandia 51
NL - Olanda 51
BD - Bangladesh 38
GB - Regno Unito 37
JP - Giappone 33
CA - Canada 29
IN - India 24
KR - Corea 21
SE - Svezia 20
AR - Argentina 19
HU - Ungheria 18
MX - Messico 17
IE - Irlanda 13
ID - Indonesia 11
IQ - Iraq 11
PH - Filippine 11
ZA - Sudafrica 11
AT - Austria 10
CI - Costa d'Avorio 10
EC - Ecuador 9
ES - Italia 9
TH - Thailandia 9
UA - Ucraina 9
IL - Israele 8
PL - Polonia 8
CO - Colombia 7
MA - Marocco 7
PK - Pakistan 7
SK - Slovacchia (Repubblica Slovacca) 7
TR - Turchia 7
TW - Taiwan 7
UZ - Uzbekistan 7
LT - Lituania 6
BE - Belgio 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
PY - Paraguay 4
AU - Australia 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
HR - Croazia 3
IR - Iran 3
NP - Nepal 3
SN - Senegal 3
TN - Tunisia 3
VE - Venezuela 3
AO - Angola 2
AZ - Azerbaigian 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
JO - Giordania 2
MT - Malta 2
MY - Malesia 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HT - Haiti 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ML - Mali 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SO - Somalia 1
SV - El Salvador 1
Totale 4.914
Città #
Singapore 366
San Jose 244
Ashburn 176
Moscow 114
Hong Kong 110
Chandler 109
Beijing 101
Ho Chi Minh City 97
Hefei 86
Hanoi 85
Naples 81
Council Bluffs 69
Santa Clara 66
Napoli 55
Amsterdam 45
Los Angeles 43
The Dalles 37
Lauterbourg 36
Munich 36
Tokyo 30
Dong Ket 28
Turku 27
New York 20
Millbury 19
Da Nang 18
Lawrence 17
Redondo Beach 17
Haiphong 16
Phoenix 16
Boston 15
Buffalo 15
Des Moines 15
Helsinki 14
Atlanta 13
Orem 13
Seoul 13
Dallas 12
Frankfurt am Main 12
São Paulo 11
Mexico City 10
Falkenstein 9
London 9
Milan 9
Poplar 9
Rome 9
Budapest 8
Fairfield 8
Washington 8
Bratislava 7
Brooklyn 7
Dublin 7
Hải Dương 7
Jacksonville 7
Princeton 7
Seattle 7
Toronto 7
Warsaw 7
Wilmington 7
Bến Tre 6
Charlotte 6
Dhaka 6
Johannesburg 6
Nanjing 6
Rio de Janeiro 6
Tashkent 6
Baghdad 5
Belo Horizonte 5
Chennai 5
Lappeenranta 5
Montreal 5
Mugnano Di Napoli 5
Mumbai 5
Nairobi 5
Ninh Bình 5
Quito 5
Stockholm 5
Szeged 5
Tel Aviv 5
Vienna 5
Brasília 4
Brussels 4
Chicago 4
Denver 4
Guangzhou 4
Manchester 4
Salt Lake City 4
Shanghai 4
Ankara 3
Bangkok 3
Biên Hòa 3
Boardman 3
Can Tho 3
Casablanca 3
Changsha 3
Cleveland 3
Cotia 3
Dakar 3
Gödöllő 3
Jakarta 3
João Pessoa 3
Totale 2.629
Nome #
The impact of cystic fibrosis on the working life of patients: A systematic review 298
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study 187
Olfactory performance in Cystic Fibrosis patients 185
The role of nasal washes in CF patients affected by chronic rhinosinusitis 182
Clinical expression of patients with the D1152H CFTR mutation 178
Cystic Fibrosis: The Sense of Smell 162
Cystic Fibrosis: the sense of smell. 161
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 155
Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers 151
Beneficial economic effect of a virtual model of care for cystic fibrosis 145
Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis 143
The role of nasal washes in patients with Cystic Fibrosis affected by chronic rhinosinusitis 143
Inhalation therapy in cystic fibrosis 142
Cystic Fibrosis in Adults: A Paradigm of Frailty Syndrome? An Observational Study 139
Lipidomic alterations in human saliva from cystic fibrosis patients 139
Clinical expression of cystic fibrosis in a large cohort of Italian siblings 139
Supervised physical exercise improves clinical, anthropometric and biochemical parameters in adult cystic fibrosis patients: A 2-year evaluation 136
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 134
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype 124
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment 123
Salivary cytokines and airways disease severity in patients with cystic fibrosis 123
Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis 120
A new method to improve the clinical evaluation of Cystic Fibrosis patients by mucus viscoelastic properties 119
Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules 119
Metabolomic profiling of saliva from cystic fibrosis patients 117
Physical activity regulates tnfα and il-6 expression to counteract inflammation in cystic fibrosis patients 112
Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment 111
Clinical outcomes of digital health in adults with cystic fibrosis 104
Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: A case report 101
Employment status and work ability in adults with cystic fibrosis 101
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 100
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes 98
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 98
Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis 86
Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis 80
Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences 75
Blood platelet reduction after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis may depend on systemic inflammation reduction 65
Effects of Oral Amino Acid Supplementation on Physical Activity, Systemic Inflammation, and Quality of Life in Adult Patients with Cystic Fibrosis: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Pilot Study 49
Pulmonary Function Modulates Epigenetic Age in Subjects with Cystic Fibrosis 37
Case Series on the Combined Therapy with Elexacaftor/Tezacaftor/Ivacaftor During Pregnancy in Women with Severe Cystic Fibrosis: A Retrospective Report from an Italian Centre 29
Totale 5.010
Categoria #
all - tutte 15.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022177 0 0 2 1 2 18 7 3 8 29 57 50
2022/2023274 25 21 15 13 34 31 5 22 53 38 12 5
2023/2024226 9 22 15 18 15 46 18 19 10 12 27 15
2024/20251.139 50 37 0 29 38 101 99 88 42 100 458 97
2025/20262.564 202 298 274 242 491 75 273 141 277 150 81 60
2026/2027392 51 267 74 0 0 0 0 0 0 0 0 0
Totale 5.010